MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
14.22
+0.07 (0.49%)
Oct 15, 2025, 1:39 PM EDT - Market open
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $64.32 million as of October 15, 2025. Its market cap has increased by 116.22% in one year.
Market Cap
64.32M
Enterprise Value
67.05M
1-Year Change
116.22%
Ranking
Category
Stock Price
$14.22
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $64.32M, a decrease of -83.35%. That is a compound annual growth rate of -36.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 64.00M | 131.73% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.98B |
| Johnson & Johnson | 458.33B |
| AbbVie | 410.39B |
| UnitedHealth Group | 324.03B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.51B |